Market News

Back

04 Feb 2026 | 17:43

Brookfield not planning to make an offer for Hikma Pharmaceuticals

(Sharecast News) - Brookfield confirmed on Wednesday that it does not plan on making an offer for Hikma Pharmaceuticals. The brief statement was made in response to recent speculation.

Join Redmayne Bentley

Talk to us now about opening a new portfolio or transferring your portfolio from another provider

0113 243 6941

Contact your local office

Contact your local office to find out more

Important

HELP

Brochures and Forms Make a Payment Frequently Asked Questions Stockbroking Charges Calculator Glossary Contact Us Site Map Investment Fraud

INFORMATION

Our Service Levels Modern Slavery Statement Consumer Duty

Fair Value Assessments

Protection of Client Assets Investment Risk MIFIDPRU 8 Public Disclosure

Investors In People (IIP)Gender Pay Gap Report

Website © Redmayne Bentley 2026
Redmayne Bentley LLP is a Limited Liability Partnership. Registered in England and Wales. Registered No: OC344361
Registered Office: 3 Wellington Place, Leeds LS1 4AP. VAT No: GB 165 8810 81. LEI: 213800S3IRIPK1R3JQ58
Members of the London Stock Exchange. Authorised and Regulated by the Financial Conduct Authority.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.